Cell-selective nanotherapy prevents vessel renarrowing and promotes healing of arteries opened by angioplasty
A USF Health preclinical study indicates nanoparticles containing a micro-RNA switch offers promising biotechnology to advance the fight against atherosclerotic cardiovascular disease Tampa, FL (Feb. 9, 2021) – […]
MicroRNAs may be crucial to normal placental development
USF Health researchers applied CRISPR technology to study the very large human non-protein coding gene expressed only in placenta, stem cells and certain cancers TAMPA, Fla (March 16, […]
USF cardiovascular researcher highlighted in “Reasons for Research” video series [video]
Hana Totary-Jain, PhD, an assistant professor of molecular pharmacology and physiology at USF Health Morsani College of Medicine, is among leading scientists from across the country who appear […]
New selective therapy may improve repair of arteries after interventional cardiovascular procedures
Preclinical study shows microRNA approach inhibited re-narrowing while healing vessels Tampa, FL (Aug. 18, 2014) — A new therapy developed by researchers at the University of South Florida […]